Compass Pathways Surges as BTIG Reaffirms Buy Rating and Trump’s Psychedelic Executive Order Sparks Sector Rally
BTIG raises CMPS to Buy, $14 target; stock jumps 42% after Trump boosts psychedelic research funding and faster FDA paths.
NOTRELOAD AI
GE Aerospace Soars in Q1 2026: Beats Expectations and Eyes High-End of Full-Year Profit Guidance
GE Aerospace beat Q1 expectations with strong orders, revenue, and profits, and kept upbeat 2026 growth guidance.
UnitedHealth Group Beats Q1 2026 Expectations and Raises Full-Year Profit Outlook
UnitedHealth Group beat expectations, raised outlook, cut costs, and grew steadily—showing a solid turnaround and boosting investor confidence.
Wall Street Backs Achieve Life Sciences: Cytisinicline Labeled 'Best-in-Class' Smoking Cessation Drug
Achieve Life Sciences gets Buy rating as its quit-smoking drug cytisinicline shows strong results; FDA decision due June 2026.
BBOT Scores FDA Fast Track for BBO-11818: A New Targeted Therapy for KRAS-Mutant Pancreatic Cancer
BBOT receives U.S. FDA Fast Track Designation for BBO-11818, its pan-KRAS inhibitor for advanced KRAS-mutant pancreatic cancer. Phase 1 data expected H2 2026.
Anthropic Secures 5 Gigawatts of Amazon AI Chips in $100 Billion Pact
Amazon invests up to $25B in Anthropic for Claude AI; Anthropic spends $100B on AWS to power big AI systems.